You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neoplasms

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01)

Recruiting
  • Digestive System Neoplasms
  • iNeo-Vac-R01
  • Hangzhou, Zhejiang, China
    Department of General Surgery, Institute of Minimally Invasive S
Sep 8, 2023

Myeloproliferative Tumors Trial (INCA033989)

Not yet recruiting
  • Myeloproliferative Neoplasms
  • (no location specified)
Sep 11, 2023

Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01 in combination with standard adjuvant therapy)

Recruiting
  • Digestive System Neoplasms
  • iNeo-Vac-R01 in combination with standard adjuvant therapy
  • Hangzhou, Zhejiang, China
    Department of General Surgery, Institute of Minimally Invasive S
Sep 8, 2023

Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01)

Recruiting
  • Digestive System Neoplasms
  • iNeo-Vac-R01
  • Hangzhou, Zhejiang, China
    Department of General Surgery, Institute of Minimally Invasive S
Sep 8, 2023

CD70-positive Advanced Urologic Tumors Trial in Shanghai (Anti-CD70 CAR-T cells)

Recruiting
  • CD70-positive Advanced Urologic Neoplasms
  • Anti-CD70 CAR-T cells
  • Shanghai, Shanghai, China
    Changhai Hospital
Aug 11, 2023

Epigenetic Age on Clinic-biological Presentation and Prognosis

Not yet recruiting
  • Myeloproliferative Neoplasm
  • Assessment of the epigenetic age
  • Bordeaux, France
    CHU de Bordeaux, service Hématologie Biologique
Aug 28, 2023

TEXTBOOK OUTCOME IN ADRENAL NEOPLASMS

Completed
  • Outcome Assessment
  • Adrenal Neoplasm
  • Adrenalectomy
  • Alicante, Spain
    Juan Jesús Rubio García
May 24, 2023

Kidney Tumors Trial in Taoyuan (multiparametric and fat-detection magnetic resonance imaging (MRI))

Active, not recruiting
  • Kidney Neoplasms
  • multiparametric and fat-detection magnetic resonance imaging (MRI)
  • Taoyuan, Taiwan
    Li-Jen Wang
Nov 9, 2023

Esophageal Tumors, Endoscopic Mucosal Resection, Hyaluronic Acid Trial in São Paulo (Submucous Endoscopic Dissection with

Recruiting
  • Esophageal Neoplasms
  • +2 more
  • Submucous Endoscopic Dissection with hydroxyethylamide
  • Submucous Endoscopic Dissection with Hyaluronic acid (TS-905 Blue Eye)
  • São Paulo, Brazil
    Instituto do Câncer do Estado de São Paulo
Oct 16, 2023

Myeloproliferative Disorders, Essential Thrombocythemia, Tumors Trial (JNJ-88549968)

Not yet recruiting
  • Myeloproliferative Disorders
  • +3 more
  • (no location specified)
Nov 21, 2023

Orthopedic Oncology Surgery: Navigation, Intraoperative Imaging

Recruiting
  • Neoplasms
  • Muscle Neoplasm
  • evaluate the quality of surgical margins achievable with the use of navigated Intraoperative CT
  • Rome, Italy
    "Regina Elena" National Cancer Institute
Jun 15, 2023

Endocrine Neoplasms

Recruiting
  • Endocrine Tumors
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Biliary Tract Tumors Trial (Total Neoadjuvant Treatment)

    Not yet recruiting
    • Biliary Tract Neoplasms
    • Total Neoadjuvant Treatment
    • (no location specified)
    Sep 7, 2023

    Endoscopic Mucosal Resection With Circumferential Incision Trial in Moscow (Endoscopic mucosal resection with circumferential

    Active, not recruiting
    • Endoscopic Mucosal Resection With Circumferential Incision
    • Endoscopic mucosal resection with circumferential incision
    • Endoscopic submucosal dissection
    • Moscow, Russian Federation
      Elmira
    Jan 10, 2023

    Carotid Plaque Burden in Philadelphia Negative

    Recruiting
    • Myeloproliferative Neoplasm
      • Sohag, Egypt
        Faculty of Medicine
      Aug 14, 2023

      Epidemiological and Clinical-pathological Factors of

      Completed
      • Myeloproliferative Neoplasm
      • +4 more
        • Guayaquil, Guayas, Ecuador
          Sociedad de Lucha Contra el Cáncer
        Apr 25, 2023

        Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial (Routine care as per

        Not yet recruiting
        • Chronic Lymphocytic Leukemia (CLL)
        • +5 more
        • Routine care as per site standard.
        • (no location specified)
        Sep 15, 2023

        ESD for the Treatment of Superficial Gastric Neoplasms

        Recruiting
        • Gastric Cancer
        • Endoscopic Submucosal Dissection
        • Rome, Italy
          Digestive Endoscopy Unit, Fondazione Policlinico Universitario A
        Jul 3, 2023

        The Myeloid Neoplasms Biology and Outcome Project

        Recruiting
        • Myeloid Neoplasm
          • Heidelberg, Baden-Württemberg, Germany
            UHHeidelberg
          Nov 21, 2022

          Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs

          Not yet recruiting
          • Myeloproliferative Neoplasms (MPNs)
          • Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)
          • (no location specified)
          Mar 24, 2023

          EBV-associated Haematologic Tumors Trial ((Autologous monocyte-derived DCs pulsed with allogeneic EBV-transformed

          Not yet recruiting
          • EBV-associated Haematologic Neoplasms
          • (Autologous monocyte-derived DCs pulsed with allogeneic EBV-transformed B-lymphoblastoid cell line lysate
          • (no location specified)
          Dec 4, 2022

          Action of Interferon in Treatment of Myeloproliferative

          Recruiting
          • Myeloproliferative Neoplasm
            • Villejuif, Ile De France, France
              Inserm U1287
            Apr 28, 2023

            Myeloid Tumor Trial in Memphis (CPX-351, MHA)

            Recruiting
            • Myeloid Neoplasm
            • Memphis, Tennessee
              St. Jude Children's Research Hospital
            Jan 20, 2023

            Hematologic Tumors Trial in Nanjing (virtual reality device)

            Recruiting
            • Hematologic Neoplasms
            • virtual reality device
            • Nanjing, Jiangsu, China
              the First Affiliated Hospital of Nanjing Medical University
            Oct 28, 2022

            Relapsed or Refractory Acute Myeloid Leukemia, Relapsed or Refractory Chronic Myelomonocytic Leukemia, Relapsed or Refractory

            Recruiting
            • Relapsed or Refractory Acute Myeloid Leukemia
            • +2 more
            • Duarte, California
            • +1 more
            Mar 14, 2023